Abstract
Adjuvant chemotherapy of gastric cancer after curative resection is still subject to discussion. In this study 137 patients with gastric adenocarcinoma, all with positive nodes, were randomized after curative resection so that 69 received epidoxorubicin (EPI), leucovorin (LV) and 5-fluorouracil (5-FU) on days 1–3 every 3 weeks for 7 months, whereas the remaining 68 did not. After a follow-up period of 5 years, 21 of the 69 treated patients (30%) and nine controls (13%) were still alive; median survival time was 18 months for the controls and 31 months for the patients treated with adjuvant chemotherapy (P< 0.01). © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alexander AR, Kelsen DP and Tepper JE (1997) Cancer of the stomach. DeVita VT, Hellman S, Rosemberg SACancer: Principles and Practice of Oncology, 1021–1054
Coombes RC, Schein PS, Chilvers CED, Wils J, Beretta G, Bliss JM, Rutten A, Amadori D, Cortes-Funes H and Villar-Grimalt A (1990) A randomized trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer. J Clin Oncol 8: 1362–1368
Decarli L and La Vecchia C (1988) Cancer mortality in Italy. Tumori 74: 6623–6632
Davis LD, Hoel D, Fox J and Lopez A (1990) International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales and the USA. Lancet 336: 474–481
Earle CC and Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer: revisiting a meta-analysis of randomized trials. Europ J Cancer 35: 1059–1064
Fenoglio-Preiser CM (1997) The effect of oncogenes on the biology and prognosis of surgically resected gastric cancer. ASCO Educational Book, 275–277
International Union Against Cancer (1987). Classification of Malignant Tumours, Hermanek P and Sobin LH (eds). Springer: Geneva
Kelsen DP (1996) Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol 23: 379–389
Michelassi F, Takanishi DM, Pantalone D, Hart J, Chappel R and Block GE (1994) Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery 116: 804–810
Nakajima T and Nishi M (1989) Surgery and adjuvant chemotherapy for gastric cancer. Hepatogastroenterology 36: 79–85
Neri B, de Leonardis V, Romano S, Andreoli F, Pernice LM, Bruno L, Borrelli D, Valeri A, Fabbroni S, Intini C and Cini G (1996) Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. Brit J Cancer 73: 549–552
SAS Institute Inc. (1987). SAS/STAT Guide for Personal Computers, Version 6 edn. SAS Institute: Cary, NC
The Gastrointestinal Tumor Study Group (1982) Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. Cancer 49: 1116–1122
Yonemura Y, Kaji M and Fushida S (1996) Correlation between over-expression of c-met gene and the progression of gastric cancer. Int J Oncol 8: 555–560
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Neri, B., Cini, G., Andreoli, F. et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br J Cancer 84, 878–880 (2001). https://doi.org/10.1054/bjoc.2000.1472
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1472
Keywords
This article is cited by
-
Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?
Medical Oncology (2013)
-
Chemotherapy for Operable Gastric Cancer: Current Perspectives
Indian Journal of Surgical Oncology (2011)
-
Adjuvant chemoradiotherapy versus surgery alone for gastric adenocarcinoma
The Chinese-German Journal of Clinical Oncology (2011)
-
Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
Cancer Chemotherapy and Pharmacology (2011)
-
Adjuvant chemotherapy with 5-FU or regimens including oral fluoropyrimidine for curable gastric cancer
Gastric Cancer (2009)